Manufacturing NewsTEG DailyNovember 19, 2026

November 19, 2026 · Tippecanoe County · Story 3 of 5

Purdue and Evonik Formalize $100 Million Lafayette Pharma Partnership

Purdue University announced on November 18 a strategic partnership with Evonik, signed August 5 on Purdue's campus, covering sponsored research, manufacturing collaboration and workforce development anchored at Evonik's Tippecanoe Laboratories in Lafayette. The agreement follows Evonik's July 7 pledge to spend $100 million over five years modernizing reactors, including 100 cubic meter units, to secure more than 650 existing jobs at the site. Purdue's Eric Woods and Evonik's Todd Wetli, Daniel Fricker, Guido Skudlarek and Michelle Brown are the named spokespeople on the deal.

The timing points to more than workforce training. Evonik's $220 million BARDA-backed Lipid Innovation Center, on the same campus, produced its first GMP lipid batch on November 10, eight days before the Purdue announcement, suggesting the partnership is built around lipid nanoparticle and mRNA delivery research. Evonik is racing Lonza, Cambrex with a $120 million API expansion, and SK pharmteco with a $200 million commitment, for the same BIOSECURE Act-driven reshoring work, while Incog BioPharma's $200 million Fishers buildout, targeting roughly 1,000 jobs by 2030, is competing for the same West-Central Indiana pharma workforce.

Impact
The timing is the real story: Evonik's $220 million BARDA-backed Lipid Innovation Center at the same campus produced its first GMP lipid batch on November 10, 2026 (eight days before the Purdue deal was announced) suggesting the partnership is built around lipid nanoparticle and mRNA delivery research, not just workforce training. Evonik is also racing Lonza, Cambrex ($120M API expansion), and SK pharmteco ($200M) for the same BIOSECURE Act-driven reshoring wave, while Incog BioPharma's $200 million Fishers buildout (targeting ~1,000 jobs by 2030) competes directly for the same West-Central Indiana pharma workforce.
Watch
The Lipid Innovation Center's push to full LNP lipid capacity by mid-2027, and any named research projects or student placements announced under the new Purdue-Evonik agreement.
For the huddle

With Evonik, Incog BioPharma, and other CDMOs racing to reshore API and lipid production under BIOSECURE Act pressure, are there supply or subcontracting opportunities for our operation feeding into this Lafayette-Fishers pharma manufacturing buildout?

Weyland is selling fabrication capacity to outside contractors starting in 2027, and Evonik's Lafayette buildout is pulling in CDMOs like Cambrex and SK pharmteco for the same reshoring wave. Both are worth a call to see if your shop qualifies as a supplier or subcontractor.

Sources

  1. Purdue and Evonik launch strategic partnership in pharmaceutical manufacturing · purdue.edu

Earlier coverage

From the brief, November 19, 2026

  1. Harris Launches $11 Million Weyland Manufacturing Plant in Elberfeld
  2. Power Up ETG Lowers Its Wage Threshold to 10 Percent
  3. Purdue and Evonik Formalize $100 Million Lafayette Pharma Partnership
  4. Indiana Holds Top U.S. Steel Ranking at 15.6 Million Metric Tons
  5. BlackRock's $33.4 Billion AES Takeover Reopens the AES Indiana Rate Case

The whole day’s brief →

This story

Related

Manufacturers Energy Grant Program

Free for Tippecanoe County manufacturers

Tippecanoe County manufacturers receive free, ongoing energy auditing and cost control that reduces their energy bills and keeps them low, month after month. Every line item checked and validated, every opportunity found comes with a step-by-step guide to capture it.

EDCs: sponsor this program and it carries your organization's name For economic developers →